204.66Delayed Data As of 4:00pm ET |  +1.77 / +0.87%Today’s Change | 166.30 Today|||52-Week Range 211.90 | +5.13% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $120.4B |
Company Description
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Employees
Shareholders
| Mutual fund holders | 45.44% |
| Other institutional | 33.95% |
| Individual stakeholders | 0.90% |
Top Executives
| There are no executives to display. |
+1.77 / +0.87%
